Abstract
COX-2 is a key factor in the progression of inflammation, the effects of a specific COX-2 inhibitor in cardiac transplantation have not yet been elucidated. To test the hypothesis that a COX-2 inhibitor can alter cardiac rejection, we analyzed graft survival using totally allomismatched grafts. Although the COX-2 inhibitor attenuated myocardial cell infiltration, the inhibitor did not prolong survival. We conclude that the COX-2 inhibition may have potential for the suppression of inflammation in cardiac allografts.
MeSH terms
-
Animals
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Graft Survival / drug effects
-
Graft Survival / immunology*
-
Heart / drug effects
-
Heart Transplantation / immunology
-
Heart Transplantation / pathology*
-
Male
-
Meloxicam
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Myocardium / pathology
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Thiazines / therapeutic use*
-
Thiazoles / therapeutic use*
-
Time Factors
-
Transplantation, Homologous / immunology
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Thiazines
-
Thiazoles
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Meloxicam